SCHEMBL15067583

SCHEMBL15067583

CCCCC(O)[CH]c1c(Cl)cccc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.36
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ HPGD P15428 2/20 0.34
▸ DRD3 P35462 2/20 0.34
▸ CTSK P43235 1/20 0.34
▸ ACHE P22303 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ DDAH1 O94760 1/20 0.33
▸ GAPDH P04406 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249523 0.82 ALDH1A1 (0.40) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL10497298 0.73 LMNA (0.45) ALDH1A1TDP1ACHEBACE1TSHR
SCHEMBL16054819 0.72 TDP1 (0.41) MEN1KMT2AALDH1A1TDP1LMNA
SCHEMBL15066089 0.72 TDP1 (0.41) MEN1KMT2AALDH1A1TDP1LMNA
SCHEMBL16055929 0.71 ALDH1A1 (0.44) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL252987 0.70 MEN1 (0.39) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL253315 0.70 MEN1 (0.39) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL253314 0.70 MEN1 (0.39) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL252530 0.70 MEN1 (0.39) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL15083014 0.70 MEN1 (0.39) MEN1KMT2AHPGDDRD3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797880-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY Bio-Pharm Solutions Co., Ltd. (KR) 2014-11-05 — — EP claimed
WO-2013100570-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILESY BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-07-04 — — WO claimed
EP-2968212-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP disclosed
EP-2968210-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY AND EPILESY-RELATED SYNDROMES Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP disclosed
WO-2014142520-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO disclosed
WO-2014142477-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILESY AND EPILESY-RELATED SYNDROMES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO disclosed
Send feedback